Maravai Lifesciences Holdings (MRVI) Market Capitalization (2020 - 2026)
Powered by 
Analysis
Maravai Lifesciences Holdings (MRVI) Market Capitalization (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 730.65 Mn |
| Dec 31, 2025 | 832.03 Mn |
| Sep 30, 2025 | 733.00 Mn |
| Jun 30, 2025 | 615.27 Mn |
| Mar 31, 2025 | 562.80 Mn |
| Dec 31, 2024 | 1.39 Bn |
| Sep 30, 2024 | 2.10 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 2.18 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 2.51 Bn |
| Jun 30, 2023 | 3.12 Bn |
| Mar 31, 2023 | 3.52 Bn |
| Dec 31, 2022 | 3.65 Bn |
| Sep 30, 2022 | 6.52 Bn |
| Jun 30, 2022 | 7.25 Bn |
| Mar 31, 2022 | 9.00 Bn |
| Dec 31, 2021 | 10.69 Bn |
| Sep 30, 2021 | 12.65 Bn |